Sort
48,018 grants matching “immunotherapy”
Type 1 Diabetes-A Proposal for Prevention & Intervention
$581,567Antoinette M Moran · University Of Minnesota · U01 · FY2017 · DK
Correlative biomarkers of IL-6 blockade combined with checkpoint inhibition
$581,524Jeffrey S Weber · New York University School Of Medicine · R01 · FY2022 · CA
Correlative biomarkers of IL-6 blockade combined with checkpoint inhibition
$581,524Jeffrey S Weber · New York University School Of Medicine · R01 · FY2023 · CA
Development of a novel therapy targeting the tumor microenvironment in inflammatory breast cancer
$581,465Naoto T Ueno · University Of Hawaii At Manoa · R01 · FY2023 · CA
Project 1: Co-stimulation and Regulation of Anti-viral Immunity
$581,348Arlene H Sharpe · Harvard Medical School · P01 · FY2020 · AI
Credentialing Mouse Models for Immune System Therapy Research
$581,304Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2017 · CA
Credentialing Mouse Models for Immune System Therapy Research
$581,304Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2016 · CA
Role of alveolar macrophage in omega-3 fatty acid amelioration of silica-triggered autoimmunity.
$581,297James J Pestka · Michigan State University · R01 · FY2023 · ES
Identification and assessment of unconventional tumor-associated antigens as potential targets for cytotoxic T-cell based immunotherapy of cancer
$581,244Gregory A Lizee · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Overcoming Immunotherapy Resistance Through Opioid Antagonism in Head and Neck Cancer
$581,147Nicole N Scheff · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DE
Genetically-engineered Bacteria Overcome Therapy Resistance
$581,087Ralph R Weichselbaum · University Of Chicago · R01 · FY2024 · CA
Systems analysis of cell-cell communication networks and immune activity in the melanoma tumor microenvironment
$581,057Kathryn Miller-Jensen · Yale University · U01 · FY2020 · CA
Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial
$581,039Lei Zheng · Johns Hopkins University · R01 · FY2021 · CA
Enhancing efficacy of vaccines for substance abuse through polymer-assisted delivery of immunomodulators
$581,016Marco Pravetoni · Hennepin Healthcare Research Institute · R01 · FY2017 · DA
VLA-4âtargeted 67Cu-LLP2A preconditioning enhances efficacy of T-cell-based adoptive immunotherapy
$580,985Ravi Bhasker Patel · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
TNF-receptors and programmed cell death in regulation of autoimmunity
$580,944Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2019 · AR
Engineering HCC-selective PET agent
$580,943Freddy Escorcia · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
$580,914Farrokh Dehdashti · Washington University · R01 · FY2020 · CA
1 of 3 Interdisciplinary Collaboratory for Enhancing Translational Therapeutics Utilizing Biologically, Immunologically, and Metabollically Relevant Models of Breast Cancer
$580,868William Joseph Murphy · University Of California At Davis · R01 · FY2015 · CA
Diversification of Cytotoxic Effector Cells Via LPS-activated DCs
$580,820Anna Karolina Palucka · Baylor Research Institute · R01 · FY2011 · CA
Development of an autologous humanized model of melanoma exploring human thymic education capacity
$580,793Antonio Jimeno · University Of Colorado Denver · R01 · FY2019 · CA
Development of an autologous humanized model of melanoma exploring human thymic education capacity
$580,793Antonio Jimeno · University Of Colorado Denver · R01 · FY2017 · CA
Mast cell regulation of Th2 induction and tolerance breakdown in food allergy
$580,728Hans C. Oettgen · Boston Children'S Hospital · R01 · FY2025 · AI
Design-driven engineering of robust mammalian sense-and-respond functions: from parts to programs
$580,634Joshua Nathaniel Leonard · Northwestern University · R01 · FY2024 · EB
Understanding IDH mutant gliomas
$580,621Jing Wu · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA